Kaya (KAYS) Stock Price, News & Analysis

Company Overview

Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics and medical cannabis dispensaries primarily in the United States. It offers a range of cannabis products, including flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. The company also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, it is involved in the development of a psychedelic treatment center under The Sacred Mushroom name, that provides its guests access to psilocybin treatments, located in Portland, Oregon. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. is headquartered in Fort Lauderdale, Florida.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.03 to $0.05
• 52-Week Range: $0.03 to $0.05
• Volume: 16,608 shs
• Average Volume: 3,171 shs
• Market Capitalization: $671,751.00
• P/E Ratio: 1.52
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KAYS Stock Analysis - Frequently Asked Questions

How have KAYS shares performed this year?

Kaya's stock was trading at $0.0421 at the beginning of 2024. Since then, KAYS shares have decreased by 28.0% and is now trading at $0.0303.
View the best growth stocks for 2024 here.

How do I buy shares of Kaya?

Shares of KAYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Kaya own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kaya investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Canopy Growth (CGC), iAnthus Capital (ITHUF), Zynerba Pharmaceuticals (ZYNE), Aurora Cannabis (ACB) and Cara Therapeutics (CARA).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Discretionary
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:KAYS
• CUSIP: N/A
• CIK: 1530746
• Web: www.kayaholdings.com
• Phone: (954) 892-6911
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.02
• Trailing P/E Ratio: 1.52
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.61 million
• Net Margins: 260.23%
• Pretax Margin: 1,305.45%
• Return on Equity: -9.79%
• Return on Assets: 652.87%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: $200,000.00
• Price / Sales: 3.36
• Cash Flow: $0.12 per share
• Price / Cash Flow: 0.26
• Book Value: ($1.07) per share
• Price / Book: -0.03

Miscellaneous

• Outstanding Shares: 22,170,000
• Free Float: 16,958,000
• Market Cap: $671,751.00
• Optionable: Not Optionable
• Beta: 0.66